1. Home
  2. VRE vs AMPH Comparison

VRE vs AMPH Comparison

Compare VRE & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRE
  • AMPH
  • Stock Information
  • Founded
  • VRE 1949
  • AMPH 1996
  • Country
  • VRE United States
  • AMPH United States
  • Employees
  • VRE N/A
  • AMPH N/A
  • Industry
  • VRE Real Estate Investment Trusts
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • VRE Real Estate
  • AMPH Health Care
  • Exchange
  • VRE Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • VRE 1.5B
  • AMPH 1.6B
  • IPO Year
  • VRE 1994
  • AMPH 2014
  • Fundamental
  • Price
  • VRE $15.66
  • AMPH $31.28
  • Analyst Decision
  • VRE Buy
  • AMPH Buy
  • Analyst Count
  • VRE 4
  • AMPH 4
  • Target Price
  • VRE $18.25
  • AMPH $50.33
  • AVG Volume (30 Days)
  • VRE 312.9K
  • AMPH 462.1K
  • Earning Date
  • VRE 02-24-2025
  • AMPH 03-03-2025
  • Dividend Yield
  • VRE 1.67%
  • AMPH N/A
  • EPS Growth
  • VRE N/A
  • AMPH 17.38
  • EPS
  • VRE N/A
  • AMPH 3.01
  • Revenue
  • VRE $293,369,000.00
  • AMPH $723,549,000.00
  • Revenue This Year
  • VRE N/A
  • AMPH $16.49
  • Revenue Next Year
  • VRE $4.53
  • AMPH $6.40
  • P/E Ratio
  • VRE N/A
  • AMPH $10.39
  • Revenue Growth
  • VRE 11.63
  • AMPH 20.33
  • 52 Week Low
  • VRE $13.84
  • AMPH $30.34
  • 52 Week High
  • VRE $18.85
  • AMPH $56.38
  • Technical
  • Relative Strength Index (RSI)
  • VRE 41.77
  • AMPH 25.63
  • Support Level
  • VRE $15.51
  • AMPH $30.34
  • Resistance Level
  • VRE $16.18
  • AMPH $32.40
  • Average True Range (ATR)
  • VRE 0.28
  • AMPH 0.87
  • MACD
  • VRE 0.00
  • AMPH 0.01
  • Stochastic Oscillator
  • VRE 29.05
  • AMPH 23.21

About VRE Veris Residential Inc.

Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: